Plan to cover anti-obesity drugs through Medicare is dropped
The Centers for Medicare and Medicaid Services said late Friday that it would not cover medications such as Wegovy that are ...
Medicare won’t cover anti-obesity GLP-1 drugs as Biden admin proposed
In November last year, the Biden administration proposed a new rule that would allow drugs like Wegovy and Zepbound to be ...
Medicare and Medicaid will not cover weight loss drugs, Trump administration decides
The Trump administration has decided against implementing a proposal for Medicare and Medicaid to cover weight loss drugs, the Centers for Medicare and Medicaid Services said in a filing published ...
The Scientist23h
Scientists Who Pioneered GLP-1 Drugs Bag Breakthrough Prize
Five scientists won this year’s Breakthrough Prize in Life Sciences for their work on GLP-1 and the development of drugs for ...
Trump administration drops Biden plan for Medicare to cover weight-loss drugs
Under the Biden administration proposal unveiled last November, an estimated 3.4 million Americans on Medicare would be eligible in 2026 for the drugs, which carry a list price of more than $1,000 a ...
The skyrocketing cost of weight-loss drugs has state Medicaid programs looking for a solution
Some of the more than a dozen states that cover the high cost of GLP-1 drugs like Wegovy, Ozempic and Zepbound through ...
Bad news for Medicare and Medicaid beneficiaries: These drugs will not be covered by the programs
The Trump administration has decided against expanding coverage to allow certain drugs to be used for weight loss in the case ...
Obituaries PGe PG Store Archives Classifieds
The Trump administration will not finalize a Biden-era plan to require coverage of anti-obesity medications in Medicare and ...